AIM IMMUNOTECH INC. Additional Paid in Capital, Common Stock
AIM IMMUNOTECH INC. (AIM) had Additional Paid in Capital, Common Stock of $417.79 million as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2022-08-15
- 2022-06-30: Additional Paid in Capital, Common Stock $417.79M.
- 2022-03-31: Additional Paid in Capital, Common Stock $417.46M.
- 2021-12-31: Additional Paid in Capital, Common Stock $417.22M.
- 2021-09-30: Additional Paid in Capital, Common Stock $416.78M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2022-06-30 | $417.79M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $417.46M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $417.22M 10-Q · filed 2022-08-15 | |
| 2021-09-30 | $416.78M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $416.44M 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $402.54M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $398.93M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $381.43M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $366.24M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $340.23M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $339.97M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $329.29M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $323.29M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $323.75M 10-K · filed 2020-03-30 | $323.70M 10-K · filed 2019-04-01 |
| 2018-09-30 | $323.36M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $322.95M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $321.63M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $317.42M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $316.75M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $316.31M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $316.24M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $315.98M 10-K · filed 2018-03-30 | |
| 2016-09-30 | $315.86M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $313.62M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $313.27M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $313.45M 10-K · filed 2017-03-31 | $313.22M 10-K · filed 2016-03-29 |
| 2015-09-30 | $313.19M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $312.76M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $308.01M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $302.73M 10-K · filed 2016-03-29 | |
| 2014-09-30 | $299.60M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $298.24M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $296.06M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $289.56M 10-K · filed 2015-03-19 | |
| 2013-09-30 | $289.20M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $289.05M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $288.93M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $288.67M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $274.67M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $265.18M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $264.99M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $264.96M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $264.93M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $264.76M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $264.51M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |